• A case report: co-occurrence of probable Vogt-Koyanagi-Harada disease and diabetic retinopathy
• A COVID-19 perspective of Vogt-Koyanagi-Harada disease
• A de novo missense mutation in MPP2 confers an increased risk of Vogt-Koyanagi-Harada disease as shown by trio-based whole-exome sequencing
• A Novel Risk Stratification-Based Immunomodulatory Treatment Strategy for Vogt-Koyanagi-Harada Disease
• A randomized non-inferiority trial of therapeutic strategy with immunosuppressants versus biologics for Vogt-Koyanagi-Harada disease
• Acute phase clinical manifestations of patients with Vogt-Koyanagi-Harada disease in Southern China
• Alteraciones en el nervio óptico y retina en pacientes con COVID-19. Una revisión teórica
• Alterations in the optic nerve and retina in patients with COVID-19. A theoretical review
• An unusual presentation of uveo-meningeoencephalitic syndrome
• An updated advancement of bifunctional IL-27 in inflammatory autoimmune diseases
• Analysis of HLA Profiles in 390 Uveitis Cases: Insights into Clinical Presentations
• Application of Ophthalmic Electrophysiology in Inflammatory Disorders of Retina and Optic Nerve
• Association of ZC3HAV1 single nucleotide polymorphisms with the susceptibility of Vogt-Koyanagi-Harada Disease
• Behcet's disease presenting as malignant hypertension induced by renovascular hypertension
• Bibliometric analysis of the Vogt-Koyanagi-Harada disease literature
• Bibliometric analysis of the Vogt‒Koyanagi‒Harada disease literature
• Bilateral peripapillary choroidal neovascular membranes in Vogt-Koyanagi-Harada disease
• Blood Whispers: Exploring Hematologic Indicators for Diagnosing and Predicting Severity of Vogt-Koyanagi-Harada Syndrome
• Categories and Profiles of Uveitis in Vogt-Koyanagi-Harada Syndrome With Systemic Correlation: Inferences From a Tertiary Multispecialty Hospital
• Challenges in posterior uveitis-tips and tricks for the retina specialist
• CHANGES IN SCLERAL THICKNESS IN THE ACUTE PHASE OF VOGT-KOYANAGI-HARADA DISEASE
• Chinese expert consensus on the clinical diagnosis and treatment of Vogt-Koyanagi-Harada syndrome (2023)
• Clinical and Transcriptional Profiles Reveal the Treatment Effect of Adalimumab in Patients with Initial-Onset and Recurrent Vogt-Koyanagi-Harada Disease
• CLINICAL FEATURES AND PROGNOSTIC VALUE OF BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE
• Clinical features, diagnosis, and management of COVID-19 vaccine-associated Vogt-Koyanagi-Harada disease
• Common practice patterns in the diagnosis and management of Vogt-Koyanagi-Harada syndrome: a survey study of uveitis specialists
• Comparisons of choroidal blood flow velocity between initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy
• Comprehensive profiling of extracellular vesicles in uveitis and scleritis enables biomarker discovery and mechanism exploration
• Comprehensive Proteomic Profiling of Aqueous Humor in Idiopathic Uveitis and Vogt-Koyanagi-Harada Syndrome
• COVID Vaccine-Associated Uveitis
• COVID-19 Developed During Systemic Steroid Therapy for Vogt-Koyanagi-Harada Disease: A Case Report
• Demographic and Clinical Characteristics of Uveitis for Adult Patients Attending Mansoura Ophthalmic Center
• Development of Vogt-Koyanagi-Harada disease-like uveitis during treatment by anti-programmed death-1 antibody: a case report
• Does Subretinal Fluid Optical Density Ratio Differ Among the Eyes with Acute Central Serous Chorioretinopathy,Vogt Koyanagi Harada Disease and Choroidal Hemangioma: A Cross-sectional Study
• Dural and Leptomeningeal Diseases: Anatomy, Causes, and Neuroimaging Findings
• Early and Late Treatment Influence on Chorioretinal Microvasculature in Vogt-Koyanagi-Harada Patients Using Optical Coherence Tomography Angiography
• EDI-OCT as an auxiliary examination for the differential diagnosis of bullous CSC and Vogt-Koyanagi-Harada: A case report
• Effect of the COVID-19 pandemic on Vogt-Koyanagi-Harada disease
• Epidemiology of Pediatric Uveitis
• Epigenome-wide association study identifies Vogt-Koyanagi-Harada disease-associated DNA methylation loci in Chinese
• Gut microbial signatures and their functions in Behcet's uveitis and Vogt-Koyanagi-Harada disease
• HIGH LONG-TERM DRUG-FREE REMISSION RATE FOR ACUTE VOGT-KOYANAGI-HARADA DISEASE WITH AN APPROPRIATE IMMUNOSUPPRESSIVE REGIMEN
• HLA-DRB1*04:05 is involved in the development of Vogt-Koyanagi-Harada disease-like immune-related adverse events in patients receiving immune checkpoint inhibitors
• Identification of FCER1G as a cyclosporin A plus corticosteroid sensitization gene in female patients with Vogt-Koyanagi-Harada disease
• Identification of Hif1α as a Potential Participant in Autoimmune Uveitis Pathogenesis Using Single-Cell Transcriptome Analysis
• Impact of Initial Management on Disease Evolution in Vogt-Koyanagi-Harada Syndrome: A Retrospective Cohort of 50 Patients
• Incidence and Risk Factors of Recurrent Anterior Uveitis in Initial Acute-Onset Vogt-Koyanagi-Harada Disease
• Indocyanine Green (ICG) Angiography
• Letter to the Editor Re: Bacillary Layer Detachment in Acute Vogt-Koyanagi-Harada Disease
• Letter to the Editor: Comment on Fauquier A et al "Impact of Initial Management on Disease Evolution in Vogt-Koyanagi-Harada Syndrome: A Retrospective Cohort of 50 Patients"
• Letter to the Editor: Comment on Fauquier A. et al. "Impact of Initial Management on Disease Evolution in Vogt-Koyanagi-Harada Syndrome: A Retrospective Cohort of 50 Patients"
• Letter to the Editor: Comment on Fonollosa et al.'s "Hyper-Reflective Outer Nuclear Layer (HONL) in Vogt-Koyanagi-Harada Disease and Sympathetic Ophthalmia"
• Literature data mining on the current research status of uveitis in China
• Multicenter and multimodal imaging study reveals rare fundus lesions in patients after SARS-CoV-2 infection
• Neovascular Glaucoma: A Rare Presenting Feature of Vogt-Koyanagi-Harada Syndrome
• Ocular Inflammation Post-Vaccination
• Ocular syphilis mimicking Vogt-Koyanagi-Harada syndrome: a diagnostic dilemma
• Optical Coherence Tomography Angiography in Vogt-Koyanagi-Harada Patients: A Systematic Review and Meta-Analysis
• OR11H1 Missense Variant Confers the Susceptibility to Vogt-Koyanagi-Harada Disease by Mediating Gadd45g Expression
• Plasma-Derived Small Extracellular Vesicles From VKH Patients Suppress T Cell Proliferation Via MicroRNA-410-3p Modulation of CXCL5 Axis
• Polyautoimmunity manifest as inflammatory myopathy, uveitis, and progressive cutaneous depigmentation in a mixed breed dog: a case report
• Predictive factors and adalimumab efficacy in managing chronic recurrence Vogt-Koyanagi-Harada disease
• Pretreatment ocular blood flow and retinal oxygen metabolism in the acute uveitic phase is associated with final outcome in Vogt-Koyanagi-Harada disease
• Prognostic value of pretreatment indocyanine green angiography in the acute uveitic phase of Vogt-Koyanagi-Harada disease
• Proteomic profiling of aqueous humor-derived exosomes in Vogt-Koyanagi-Harada disease and Behcet's uveitis
• Quantitative and comparative analysis of thermography parameters in posterior scleritis, choroiditis, and controls
• Reactivation of previously controlled Vogt-Koyanagi-Harada disease more than 46 years following COVID-19 vaccination: a case study
• Recurrent chronic Vogt-Koyanagi-Harada syndrome or sarcoidosis? A Gloomy diagnosis
• RWC Update: Improving Surgical Outcomes With Intraoperative Fluorescein Angiography; Myopic Macular Holes - When to Operate?; Harada's Disease
• Single Low-dose Suprachoroidal Triamcinolone Acetonide Injection in Macular Edema Secondary to Noninfectious Posterior Uveitis
• SS OCT and OCT-A Findings in Convalescent Inactive Vogt-Koyanagi-Harada Disease
• Surgical management for treatment-resistant cases of inflammatory exudative retinal detachment: Mission impossible?
• Surgical management of a case of non-resolving bullous retinal detachment due to probable Vogt-Koyanagi-Harada syndrome
• TET2-mediated upregulation of 5-hydroxymethylcytosine in LRRC39 promoter promotes Th1 response in association with downregulated Treg response in Vogt-Koyanagi-Harada disease
• The Frequency of Intraocular Pressure Elevation, Incidence of Secondary Glaucoma, and Surgical Treatment With Postoperative Complications in Pediatric and Adult Patients With Uveitis
• The Incidence and Presentation Features of Glaucoma in Vogt-Koyanagi-Harada Syndrome: A Systematic Review and Meta-Analysis
• The skin, the eyes, and the ears in Vogt-Koyanagi-Harada disease (VKHD)
• Therapeutic Effects of Upadacitinib on Experimental Autoimmune Uveitis: Insights From Single-Cell Analysis
• Ultrasonographic study of the orbit as an early diagnostic tool in Vogt Koyanagi Harada disease (VKH): A case report
• Unilateral Posterior Uveitis in a Patient Receiving Nivolumab for Malignant Melanoma
• Uveitis including Vogt-Koyanagi-Harada syndrome following inactive covid-19 vaccination: a case series
• Very early OCT response to intravenous pulse steroid in Vogt-Koyanagi-Harada disease
• Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease
• VKH disease in the elderly: Variations in clinical course as compared to VKH disease in adults
• VKH with APECED in a Two-Year-Old Child: A Rare Concomitant Diagnosis in an Unprecedented Age
• VKH-like syndrome in the setting of Dabrafenib and Trametinib therapy for BRAF mutant metastatic melanoma: a case report
• Vogt-Koyanagi-Harada Disease
• Vogt-Koyanagi-Harada disease after SARS-CoV-2 infection: Case report and literature review
• Vogt-Koyanagi-Harada disease developed during chemotherapy for Hodgkin lymphoma: a case report
• Vogt-Koyanagi-Harada disease in pediatric, adult and elderly: clinical characteristics and visual outcomes
• Vogt-Koyanagi-Harada disease-like uveitis after drug therapy including BRAF/MEK inhibitors in melanoma patients with HLA-DRB1*04
• VOGT-KOYANAGI-HARADA DISEASE-LIKE UVEITIS IN A PATIENT WITH ADVANCED MELANOMA TREATED BY SEQUENTIAL ADMINISTRATION OF NIVOLUMAB AND DABRAFENIB/TRAMETINIB THERAPY
• Vogt-Koyanagi-Harada Disease: A Narrative Review
• Vogt-Koyanagi-Harada Disease: The Clinical Spectrum and Management of Case Series in a Tertiary Eye Centre in Northern Part Of Malaysia
• Vogt-Koyanagi-Harada Syndrome
• Vogt-Koyanagi-Harada Syndrome (VKHS): First Two Cases Reported in Pediatric Age Group in Oman
• Vogt-Koyanagi-Harada Syndrome Following COVID-19 mRNA Vaccination: Th2 to Th1 Transition-related Molecular Machinery
• Vogt-Koyanagi-Harada Syndrome: A Case Report
• Vogt-Koyanagi-Harada-like Syndrome after Cadonilimab (PD-1/CTLA-4 Inhibition) for Metastatic Uveal Melanoma
• Vogt-Koyanagi-Harada-like Syndrome Induced by Checkpoint Inhibitor Cemiplimab